Update your clinical practice with this exploration into the latest drug therapies for HIV. In this dynamic session, a thorough catalog of antiretroviral agents are analyzed in conjunction with the basic tenets of treatment programs, including HIV pre-exposure prophylaxis (PrEP).
In addition, this CE offering informs you on the best candidates for PrEP, as well as the particular caveats associated with these prophylactic medications. Explicit monitoring parameters for the agents used in PrEP are given and discussed in accordance with issues in medication adherence and cost concerns.
Sample